• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Will a Medco/Express Scripts Merger Pass Regulatory Muster?

    Shareholders would be well-served by the pharmacy benefit managers' merger, but regulators are unlikely to sign off on it, says Morningstar's Matt Coffina.

  2. Cautious Optimism for More M&A Activity in 2013

    Growing corporate cash balances and slowing organic-growth opportunities could lead to increased deal volume this year even if economic uncertainty throttles some activity, says Morningstar's Bridget Freas.

  3. Weighing Berkshire's Acquisition Prospects

    Are Berkshire's best acquisition days behind it? Berkshire authors weigh in.

  4. Method Behind Merger-Arbitrage and Managed Futures

    AQR's Cliff Asness describes the strategies behind the firm's merger-arbitrage and managed futures funds.

  1. Winds of Change in Russia’s Retail Sector

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

  2. Valeant Pharmaceuticals International VRX Q4 2010 Earnings Call Transcript

    Good morning. My name is Sean and I'll be your conference operator today. At this time, I would like to welcome everyone to the Valeant Pharmaceuticals 2010 Fourth Quarter Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' ...

  3. Valeant Pharmaceuticals International VRX Q1 2011 Earnings Call Transcript

    Good morning. My name is Sara and I will be your conference operator today. At this time, I would like to welcome everyone to the Valeant Pharmaceuticals First Quarter 2011 Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, ...

  4. Valeant Pharmaceuticals International VRX Q2 2011 Earnings Call Transcript

    Good morning. My name is Stephanie and I will be your conference operator today. At this time, I would like to welcome everyone to the Valeant Pharmaceuticals Second Quarter Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will ...

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.